New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
Vancouver, Canada, January 6, 2026 – Eminent Gold Corp. (TSX-V: EMNT | OTCQB: EMGDF | FSE: 7AB) (“Eminent” or the “Company”) ...
The 74 reports a decline in parents reading to children, linked to past negative experiences and digital distractions, ...
The number of orbital launch attempts worldwide last year surpassed the record 2024 flight rate by 25 percent, with SpaceX ...
Group, the insurance and business solutions provider dedicated to the jewelry industry since 1913, announced the strategic acquisition of EventGuard, a division previously part of the licensed ...
CACI has shaped its business almost entirely around national security, with the vast majority of revenue coming from defense, ...
Stellantis Puts Customer Choice Front and Center at the 2026 Detroit Auto Show With New Vehicles, Iconic Returns and ...
Genesis Motor Europe marks a year of significant milestones for the brand Commitment to a fully electrified product range in ...
VANCOUVER, BC, Jan. 6, 2026 /CNW/ - Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) (FSE: 7AB) ("Eminent" or the "Company") is ...
Q2 2026 Earnings Call Transcript January 8, 2026 Operator: Good day, and thank you for standing by. Welcome to the Richardson ...
The bill would cut the Office of Fossil Energy down to $720 million, including $140 million in prior year balances from the ...
Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results